Brazil New Coronavirus Vaccine Development Competition Overheated June 12, 13:20
k10012468011_202006121318_202006121322.mp4
The state government of Sao Paulo, Brazil, South America, announced yesterday that it has agreed to conduct a final-stage trial on a new coronavirus vaccine under development by a Chinese state-owned enterprise from next month on 9,000 people. In Brazil, the final stage trial will be conducted from next week on a vaccine under development by a university in England.
The vaccine developed by Chinese state-owned enterprises is that up to the second stage trial to confirm the safety and efficacy has already been given to 1,000 people in China.
The state government of São Paulo, Brazil, has agreed with the Chinese side on January 11 that it will inoculate more people and carry out a final stage 3 trial in Sao Paulo to confirm safety and efficacy over a long period of time. Announced.
Specifically, it will start vaccination of 9,000 people including medical personnel next month, and will verify the effect over a year.
Regarding the development of vaccines, the final stage 3 trial will be conducted in Brazil from next week on the vaccines being developed by the University of Oxford in the UK and supported by the United States.
Brazil still has over 1,000 deaths a day, the second-highest number of people after the United States, and the vaccine race in Brazil is heating up.